JF
CGEM icon

Jump Financial’s Cullinan Oncology CGEM Stock Holding History

Jump Financial’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.53M Sell
138,708
-55,092
-28% -$818K 0.02% 796
2026
Q1 		$2.75M Sell
193,800
-171,089
-47% -$2.2M 0.04% 538
2025
Q4 		$3.78M Buy
364,889
+170,382
+88% +$1.54M 0.05% 450
2025
Q3 		$1.15M Buy
+194,507
New +$1.42M 0.01% 956
2025
Q1 		– Sell
-66,135
Closed -$806K – 1627
2024
Q4 		$806K Buy
66,135
+37,469
+131% +$539K 0.02% 849
2024
Q3 		$480K Sell
28,666
-8,796
-23% -$156K 0.01% 1121
2024
Q2 		$653K Buy
37,462
+15,772
+73% +$336K 0.01% 1016
2024
Q1 		$370K Buy
+21,690
New +$335K 0.01% 1338
2022
Q4 		– Sell
-21,700
Closed -$278K – 1611
2022
Q3 		$278K Sell
21,700
-20,700
-49% -$279K 0.01% 1184
2022
Q2 		$544K Buy
42,400
+22,522
+113% +$255K 0.02% 821
2022
Q1 		$208K Buy
19,878
+7,778
+64% +$105K 0.01% 1287
2021
Q4 		$187K Buy
+12,100
New +$241K 0.01% 1129

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Jump Financial's CGEM Position: Q2 2026 in Review

Jump Financial reduced its Cullinan Oncology (CGEM) stake by 28% in Q2 2026, selling an estimated $818K and leaving 138,708 shares worth $2.53M. The position accounts for 0.02% of the portfolio, ranked #796.

Jump Financial first reported a position in CGEM in Q4 2021 and has held it in 12 quarters since. The position peaked at $3.78M in Q4 2025. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Jump Financial held 138,708 shares of Cullinan Oncology worth $2.53M as of Q2 2026.
  • Jump Financial sold 55,092 Cullinan Oncology shares in Q2 2026, an estimated $818K.
  • Cullinan Oncology made up 0.02% of Jump Financial's portfolio in Q2 2026, its #796 holding.
  • Jump Financial first reported a position in Cullinan Oncology in Q4 2021 and has held it in 12 quarters since.
  • Jump Financial's Cullinan Oncology position peaked at $3.78M in Q4 2025.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.